Sort
141,003 grants matching “cytokine”
Operation Core-ACISR for Late-Life Depression Prevention
$715,016Charles F Reynolds · University Of Pittsburgh At Pittsburgh · P30 · FY2013 · MH
Bromine Inhalation Induced Lung Injury: Novel Mechanisms and Treatment Strategies
$714,998Sadis Matalon · University Of Alabama At Birmingham · U01 · FY2016 · ES
Copper transport protein and inflammatory angiogenesis
$714,984Tohru Fukai · University Of Illinois At Chicago · R01 · FY2014 · HL
Regulation of NF-Kappa B
$714,981Inder Mohan Verma · Salk Institute For Biological Studies · R01 · FY2012 · AI
Regulation of NF-Kappa B
$714,981Inder Mohan Verma · Salk Institute For Biological Studies · R01 · FY2014 · AI
GENETIC MODIFIERS OF SEVERITY IN SICKLE CELL ANEMIA
$714,974Children'S Hospital Boston · R01 · FY2003 · HL
Determinants of T Cell Fate in Transplantation Tolerance
$714,964Mandy L. Ford · Emory University · R01 · FY2024 · AI
Determinants of T Cell Fate in Transplantation Tolerance
$714,964Mandy L. Ford · Emory University · R01 · FY2023 · AI
Determinants of T Cell Fate in Transplantation Tolerance
$714,964Mandy L. Ford · Emory University · R01 · FY2025 · AI
Determinants of T Cell Fate in Transplantation Tolerance
$714,964Mandy L. Ford · Emory University · R01 · FY2022 · AI
CoPARC: Colorado Pulmonary Alcohol Research Collaborative
$714,928Ellen L Burnham · University Of Colorado Denver · R24 · FY2019 · AA
Rapid Immune Restoration and Lung Injury in HIV/TB
$714,852Gregory P. Bisson · University Of Pennsylvania · R01 · FY2018 · AI
Genomic targets of oncoproteins and tumor suppressors
$714,829Kevin Struhl · Harvard Medical School · R01 · FY2017 · CA
Genomic targets of oncoproteins and tumor suppressors
$714,829Kevin Struhl · Harvard Medical School · R01 · FY2016 · CA
Genomic targets of oncoproteins and tumor suppressors
$714,829Kevin Struhl · Harvard Medical School · R01 · FY2020 · CA
GENETIC, IMMUNOLOGIC AND MECHANISTIC BASIS OF HUMAN NK CELL DEFICIENCY
$714,827Jordan Scott Orange · Baylor College Of Medicine · R01 · FY2017 · AI
Retinal Disease: Molecular Basis and Pathophysiology
$714,791Patsy M Nishina · Jackson Laboratory · R01 · FY2023 · EY
Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome
$714,789Carrie E Bearden · University Of California Los Angeles · R01 · FY2016 · MH
Tailoring Novel Therapeutics for Emerging Drug-Resistant C. Difficile Colitis
$714,786Richard L Guerrant · University Of Virginia · U01 · FY2009 · AI
Natural Killer cells and the Immunogenetics of COVID-19
$714,785Paul John Norman · University Of Colorado Denver · R01 · FY2022 · AI
Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle
$714,771Anthony N Gerber · National Jewish Health · R01 · FY2025 · HL
Identifying a novel pathway that regulates RA immunometabolism
$714,758Shiva Shahrara · University Of Illinois At Chicago · R01 · FY2025 · AI
Identifying a novel pathway that regulates RA immunometabolism
$714,758Shiva Shahrara · University Of Illinois At Chicago · R01 · FY2023 · AI
Mechanistic elucidation of pathogenic CBM complex mutations associated with atopic disease
$714,722Andrew L Snow · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2023 · AI
PBMCs, Exercise, and Children: Initial Mechanisms
$714,702University Of California Irvine · R01 · FY2005 · HL